Japan
· Delayed Price · Currency is JPY Ono Pharmaceutical Statistics
Total Valuation
Ono Pharmaceutical has a market cap or net worth of JPY 935.77 billion. The enterprise value is 953.14 billion.
| Market Cap | 935.77B |
| Enterprise Value | 953.14B |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | Sep 27, 2024 |
Share Statistics
Ono Pharmaceutical has 469.64 million shares outstanding. The number of shares has decreased by -3.83% in one year.
| Shares Outstanding | 469.64M |
| Shares Change (YoY) | -3.83% |
| Shares Change (QoQ) | -0.51% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 48.71% |
| Float | 383.26M |
Valuation Ratios
The trailing PE ratio is 7.83 and the forward PE ratio is 12.43.
| PE Ratio | 7.83 |
| Forward PE | 12.43 |
| PS Ratio | 1.89 |
| PB Ratio | 1.15 |
| P/FCF Ratio | 7.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.69, with an EV/FCF ratio of 8.13.
| EV / Earnings | 7.88 |
| EV / Sales | 1.91 |
| EV / EBITDA | 5.69 |
| EV / EBIT | 6.37 |
| EV / FCF | 8.13 |
Financial Position
The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.20.
| Current Ratio | 1.53 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.39 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 15.28% and return on invested capital (ROIC) is 10.65%.
| Return on Equity (ROE) | 15.28% |
| Return on Assets (ROA) | 9.56% |
| Return on Capital (ROIC) | 10.65% |
| Revenue Per Employee | 129.85M |
| Profits Per Employee | 31.39M |
| Employee Count | 3,853 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.45% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -27.45% |
| 50-Day Moving Average | 2,054.41 |
| 200-Day Moving Average | 2,298.89 |
| Relative Strength Index (RSI) | 49.29 |
| Average Volume (20 Days) | 1,955,495 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ono Pharmaceutical had revenue of JPY 500.33 billion and earned 120.95 billion in profits. Earnings per share was 254.37.
| Revenue | 500.33B |
| Gross Profit | 373.71B |
| Operating Income | 149.64B |
| Pretax Income | 154.67B |
| Net Income | 120.95B |
| EBITDA | 167.63B |
| EBIT | 149.64B |
| Earnings Per Share (EPS) | 254.37 |
Balance Sheet
The company has 150.92 billion in cash and 162.61 billion in debt, giving a net cash position of -11.69 billion or -24.89 per share.
| Cash & Cash Equivalents | 150.92B |
| Total Debt | 162.61B |
| Net Cash | -11.69B |
| Net Cash Per Share | -24.89 |
| Equity (Book Value) | 816.41B |
| Book Value Per Share | 1,726.26 |
| Working Capital | 134.54B |
Cash Flow
In the last 12 months, operating cash flow was 121.11 billion and capital expenditures -3.89 billion, giving a free cash flow of 117.22 billion.
| Operating Cash Flow | 121.11B |
| Capital Expenditures | -3.89B |
| Free Cash Flow | 117.22B |
| FCF Per Share | 249.60 |
Margins
| Gross Margin | n/a |
| Operating Margin | 29.91% |
| Pretax Margin | 30.91% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 23.43% |
Dividends & Yields
This stock pays an annual dividend of 80.00, which amounts to a dividend yield of 3.94%.
| Dividend Per Share | 80.00 |
| Dividend Yield | 3.94% |
| Dividend Growth (YoY) | 3.90% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | 3.83% |
| Shareholder Yield | 7.77% |
| Earnings Yield | 12.77% |
| FCF Yield | 12.53% |
Stock Splits
The last stock split was on March 29, 2016. It was a forward split with a ratio of 5.
| Last Split Date | Mar 29, 2016 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |